Method for determining insulin sensitivity with biomarkers
View Patent ↗Biomarkers relating to insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy. In addition, methods for modulating the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy.
1. A method of determining insulin sensitivity in a subject, the method comprising: predicting a glucose disposal rate in a subject by analyzing a biological sample from a subject to determine a level(s) of 2-hydroxybutyrate and one or more biomarkers for insulin resistance in the sample, wherein the one or more biomarkers are selected from the group consisting of linoleoyl LPC, oleoyl LPC, oleate, linolenate, linoleate, glycerophosphorylcholine (GPC), and stearate; and comparing the level(s) of 2-hydroxybutyrate and the one or more biomarkers in the sample to glucose disposal reference levels of 2-hydroxybutyrate and the one or more biomarkers in order determine insulin sensitivity in the subject.
2. The method of claim 1 , wherein the method further comprises determining the subject's measurements of fasting plasma insulin, fasting plasma glucose, fasting plasma pro-insulin, fasting free fatty acids, HDL-cholesterol, LDL-cholesterol, C-peptide, adiponectin, peptide YY, hemoglobin A1C, waist circumference, body weight, or body mass index.
3. The method of claim 2 , wherein the method comprises analyzing the subject and a biological sample from the subject using a mathematical model comprising 2-hydroxybutyrate and one or more biomarkers or measurements selected from the group consisting of, linoleoyl LPC, oleoyl LPC, oleate, linolenate, linoleate, glycerophosphorylcholine (GPC), stearate, fasting plasma insulin, fasting plasma glucose, fasting plasma pro-insulin, fasting free fatty acids, HDL-cholesterol, LDL-cholesterol, C-peptide, adiponectin, peptide YY, hemoglobin A1C, waist circumference, body weight, and body mass index.
4. The method of claim 3 , wherein the predicted glucose disposal rate is calculated by means of one of the following mathematical models:
M=A +B (BMI)+ C (insulin)+ D (2-hydroxybutyrate)+ E (linoleoyl LPC )+ F (oleate), or a)
ln( M )= A +B *ln(BMI)+ C *ln(insulin)+ D *ln(2-hydroxybutyrate)+ E *ln(linoleoyl LPC )+ F *ln(oleate), b)
wherein A, B, C, D, E, and F are constant numbers; (BMI), (insulin), (2-hydroxybutyrate), (linoleoyl LPC), and (oleate), respectively, which are measured values of the analyte; and M is the predicted glucose disposal rate.
5. The method of claim 3 , wherein the predicted glucose disposal rate is calculated by means of one of the following mathematical models;
M=A +B (BMI)+ C (2-hydroxybutyrate)+ D (linoleoyl- LPC )+ E (oleate), or a)
ln( M )= A +B *ln(BMI)+ C *ln(2-hydroxybutyrate)+ D *ln(linoleoyl LPC )+ E *ln(oleate), b)
wherein A, B, C, D, and E are constant numbers; (BMI), (2-hydroxybutyrate), (linoleoyl LPC), and (oleate), respectively, which are the measured values of the analyte; and M is the predicted glucose disposal rate.
6. The method of claim 1 , wherein the method comprises analyzing the biological sample to determine the level of 2-hydroxybutyrate, linoleoyl LPC, oleoyl LPC, oleate, linolenate, linoleate, glycerophosphorylcholine (GPC), and stearate.
7. The method of claim 1 , wherein the biological sample is a plasma sample.
8. A method of determining insulin sensitivity in a cat, the method comprising: analyzing a biological sample from a cat to determine a level(s) of 2-hydroxybutyrate and one or more biomarkers for insulin resistance in the sample, wherein the one or more biomarkers are selected from the group consisting of, linoleoyl LPC, creatine, palmitate, decanoyl carnitine, oleoyl LPC, oleate, linolenate, GPC, and stearate; and comparing the level(s) of 2-hydroxybutyrate and the one or more biomarkers in the sample to glucose disposal reference levels of 2-hydroxybutyrate and the one or more biomarkers in order to determine insulin sensitivity in the cat.
9. A method of classifying a cat according to glucose tolerance from normal glucose tolerance (NGT), to impaired fasting glucose tolerance (IFG), to impaired glucose tolerance (IGT), the method comprising: analyzing a biological sample from a cat to determine a level(s) of 2-hydroxybutyrate and one or more biomarkers for glucose tolerance in the sample, wherein the one or more biomarkers are selected from the group consisting of, linoleoyl LPC, creatine, palmitate, decanoyl carnitine, oleoyl LPC, oleate, linolenate, GPC, and stearate; and comparing the level(s) of 2-hydroxybutyrate and the one or more biomarkers in the sample to glucose tolerance reference levels of 2-hydroxybutyrate and the one or more biomarkers in order to classify the cat as having NGT, IFG, or IGT.
10. A method of determining insulin sensitivity in a subject, the method comprising: analyzing a biological sample from a subject to determine a level(s) of 2-hydroxybutyrate and linoleoyl LPC and one or more biomarkers for insulin resistance in the sample, wherein the one or more biomarkers are selected from the group consisting of oleoyl LPC, oleate, linolenate, linoleate, glycerophosphorylcholine (GPC), and stearate; and comparing the level(s) of 2-hydroxybutyrate, linoleoyl LPC and the one or more biomarkers in the sample to glucose disposal reference levels of 2-hydroxybutyrate, linoleoyl LPC and the one or more biomarkers in order to determine insulin sensitivity in the subject.
11. A method of determining insulin sensitivity in a subject, the method comprising: analyzing a biological sample from a subject to determine a level(s) of 2-hydroxybutyrate, oleate and one or more biomarkers for insulin resistance in the sample, wherein the one or more biomarkers are selected from the group consisting of linoleoyl LPC, oleoyl LPC, linolenate, linoleate, glycerophosphorylcholine (GPC), and stearate; and comparing the level(s) of 2-hydroxybutyrate, oleate and the one or more biomarkers in the sample to glucose disposal reference levels of 2-hydroxybutyrate, oleate and the one or more biomarkers in order to determine insulin sensitivity in the subject.
12. A method of determining insulin sensitivity in a subject, the method comprising: analyzing a biological sample from a subject to determine a level(s) of 2-hydroxybutyrate and one or more biomarkers for insulin resistance in the sample, wherein the one or more biomarkers are selected from the group consisting of linoleoyl LPC, oleoyl LPC, oleate, linolenate, linoleate, glycerophosphorylcholine (GPC), and stearate; and comparing the level(s) of 2-hydroxybutyrate and the one or more biomarkers in the sample to glucose disposal reference levels of 2-hydroxybutyrate and the one or more biomarkers in order to determine insulin sensitivity in the subject.